$AXON Sio Gene Therapies Inc. Insider Trading Week 15/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Sio Gene Therapies Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Sio Gene Therapies Inc. in week 15/2019.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 17 2019 | AXON | Axovant Sciences L ... | Pande Atul | Director | Option Exercise | A | 1.06 | 255,000 | 270,300 | 255,000 | |
Apr 17 2019 | AXON | Axovant Sciences L ... | Bickerstaff George | Director | Option Exercise | A | 1.06 | 255,000 | 270,300 | 255,000 | |
Apr 17 2019 | AXON | Axovant Sciences L ... | POTTER MYRTLE S | Director | Option Exercise | A | 1.06 | 255,000 | 270,300 | 255,000 | |
Apr 17 2019 | AXON | Axovant Sciences L ... | Torti Frank | Director | Option Exercise | A | 1.06 | 255,000 | 270,300 | 255,000 | |
Apr 17 2019 | AXON | Axovant Sciences L ... | Corcoran Gavin | EVP of R&D | Option Exercise | A | 1.06 | 200,000 | 212,000 | 200,000 | |
Apr 17 2019 | AXON | Axovant Sciences L ... | Corcoran Gavin | EVP of R&D | Option Exercise | A | 1.06 | 767,000 | 813,020 | 767,000 | |
Apr 17 2019 | AXON | Axovant Sciences L ... | Modig Berndt | Director | Option Exercise | A | 1.06 | 255,000 | 270,300 | 255,000 | |
Apr 17 2019 | AXON | Axovant Sciences L ... | Cheruvu Pavan | Chief Executive Off ... | Option Exercise | A | 1.06 | 1,596,000 | 1,691,760 | 1,596,000 | |
Apr 17 2019 | AXON | Axovant Sciences L ... | Cheruvu Pavan | Chief Executive Off ... | Option Exercise | A | 1.06 | 1,596,000 | 1,691,760 | 1,596,000 | |
Apr 17 2019 | AXON | Axovant Sciences L ... | Bazley Mathew C. | General Counsel | Option Exercise | A | 1.06 | 250,000 | 265,000 | 250,000 | |
Apr 17 2019 | AXON | Axovant Sciences L ... | Bazley Mathew C. | General Counsel | Option Exercise | A | 1.06 | 726,000 | 769,560 | 726,000 | |
Apr 17 2019 | AXON | Axovant Sciences L ... | JEFFS ROGER | Director | Option Exercise | A | 1.06 | 255,000 | 270,300 | 255,000 |